pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

63 catalysts · 28 grant · 23 approval · 5 device 510k · 5 device pma · 2 device recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 118 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-05×to 2026-02-05×clear all
type
  • grant28
  • approval23
  • device 510k5
  • device pma5
  • device recall2
therapy area

no tagged catalysts yet

Week of Feb 2, 2026

50
›Feb 5, 2026approval190d agoAZTREONAM — FDA approvalAZTREONAM

Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

full page →AZTREONAM →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalExtrovis AG

Sponsor: KINDOS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗
›Feb 5, 2026approval190d agoNICOTINE POLACRILEX — FDA approvalPL Developments Copiague LLC

Sponsor: P AND L. Form: GUM, CHEWING. Route: BUCCAL

full page →fda approvals ↗
›Feb 5, 2026approval190d agoNYSTATIN — FDA approvalActavis Mid Atlantic LLC

Sponsor: STERANCO HLTHCARE. Form: SUSPENSION. Route: ORAL

full page →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalExtrovis AG

Sponsor: KINDOS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗
›Feb 5, 2026approval190d agoBUMETANIDE — FDA approvalBUMETANIDE

Sponsor: MSN. Form: TABLET. Route: ORAL

full page →BUMETANIDE →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalExtrovis AG

Sponsor: EUGIA PHARMA SPECLTS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalExtrovis AG

Sponsor: EUGIA PHARMA SPECLTS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗
›Feb 5, 2026approval190d agoPRUCALOPRIDE SUCCINATE — FDA approvalSpecGx LLC

Sponsor: TEVA PHARMS INC. Form: TABLET. Route: ORAL

full page →fda approvals ↗
›Feb 5, 2026approval190d agoCARBIDOPA, LEVODOPA AND ENTACAPONE (CARBIDOPA) — FDA approvalcarbidopa

Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

full page →carbidopa →fda approvals ↗
›Feb 5, 2026approval190d agoMYQORZO (AFICAMTEN) — FDA approvalaficamten

Sponsor: CYTOKINETICS. Form: TABLET. Route: ORAL

full page →aficamten →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗
›Feb 5, 2026approval190d agoHYDROCORTISONE SODIUM SUCCINATE — FDA approvalHYDROCORTISONE SODIUM SUCCINATE

Sponsor: APOTEX. Form: INJECTABLE. Route: INJECTION

full page →HYDROCORTISONE SODIUM SUCCINATE →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalExtrovis AG

Sponsor: NOVAST LABS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: ALEMBIC. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalExtrovis AG

Sponsor: NOVAST LABS. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗
›Feb 5, 2026approval190d agoZOLEDRONIC ACID — FDA approvalZOLEDRONIC ACID

Sponsor: GLAND. Form: INJECTABLE. Route: INTRAVENOUS

full page →ZOLEDRONIC ACID →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: ALEMBIC. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗
›Feb 5, 2026approval190d agoFLUOROURACIL — FDA approvalEfudex

Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

full page →Efudex →fda approvals ↗
›Feb 5, 2026device 510k190d agoEncora, Inc. — Encora X1 (510k cleared)Encore Inc.

Product code: QBC. Advisory committee: Neurology. Type: Traditional

full page →fda device 510k ↗
›Feb 5, 2026device 510k190d agoDentsply Sirona — Primevision 3D (510k cleared)DENTSPLY SIRONA Inc.

Product code: OAS. Advisory committee: Radiology. Type: Traditional

full page →fda device 510k ↗
›Feb 5, 2026device 510k190d agoGe Medical Systems, LLC — SIGNA™ Sprint Select (510k cleared)

Product code: LNH. Advisory committee: Radiology. Type: Traditional

full page →fda device 510k ↗
›Feb 5, 2026device 510k190d agoPenumbra, Inc. — INDIGO® Aspiration System - Lightning Flash Aspiration Tubing with LINK (510k cleared)Penumbra Inc

Product code: QEW. Advisory committee: Cardiovascular. Type: Traditional

full page →fda device 510k ↗
›Feb 5, 2026device 510k190d agoArgon Medical Devices, Inc. — CLEANER™ Vac Thrombectomy System, CLEANER™ Vac Aspiration Catheter with Handpiece, CLEANER™ Vac Aspiration Canister (510k cleared)

Product code: QEW. Advisory committee: Cardiovascular. Type: Special

full page →fda device 510k ↗
›Feb 5, 2026device pma190d agoW. L. Gore & Associates, Inc. — GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (PMA supplement)

Supplement type: 30-Day Notice. Product code: PRL. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Feb 5, 2026device pma190d agoAbbott Vascular (Idef Technologies Inc) — Supera Peripheral Stent System (PMA supplement)

Supplement type: 30-Day Notice. Product code: NIP. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Feb 5, 2026device pma190d agoArj Medical, Inc. — PyloPlus UBT System (PMA supplement)AVITA Medical, Inc.

Supplement type: Normal 180 Day Track. Product code: OZA. Advisory committee: MI. Decision: APPR

full page →fda device pma ↗
›Feb 5, 2026device pma190d agoQ-Med AB — Restylane Lyft with Lidocaine (PMA supplement)Sustained Therapeutics Inc

Supplement type: 30-Day Notice. Product code: LMH. Advisory committee: SU. Decision: OK30

full page →fda device pma ↗
›Feb 5, 2026device pma190d agoAbbott Vascular — XIENCE Alpine Everolimus Eluting Coronary Stent System (XIENCE Alpine); XIENCE Sierra Everolimus Eluting Coronary Stent (PMA supplement)Postsurgical Therapeutics Inc

Supplement type: 30-Day Notice. Product code: NIQ. Advisory committee: CV. Decision: OK30

full page →fda device pma ↗
›Feb 5, 2026device recall190d agoDiagnostica Stago, Inc. device recall (Cls II)

Brand Name: STA Liatest D-Di Product Name: STA Liatest D-Di Model/Catalog Number: REF 00515 Product Description: The STA¿ - Liatest ¿ D-Di kit is an immuno-turbidimetric assay for the quantitative determination of D-dimer in venous plasma (in 3.2 % sodium citrate) for use on STA-R¿, STA Compact¿ and STA Satellite¿ analyzers by professional laboratory personnel. The STA¿ - Liatest¿ D-Di is intended for use in conjunction with a clinical pretest probability (PTP) assessment model to exclude pulmonary embolism (PE) and deep venous thrombosis (DVT) in outpatients suspected of PE or DVT. Component: No — Reason: After receiving customer complaints, investigations confirmed the presence of a positive bias in D-Dimer measurements throughout the entire analytical range. — Status: Ongoing

full page →fda device recalls ↗
›Feb 5, 2026device recall190d agoRemel, Inc device recall (Cls II)

Campy CVA Medium 100/PK, R01272 — Reason: Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium. — Status: Ongoing

full page →fda device recalls ↗
›Feb 5, 2026grant190d agoBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — Molecular Mechanisms Governing Non-canonical miR-146a BiogenesisCity of Hope

AI grant. $489,500. PI: Mark P Boldin

full page →nih reporter ↗
›Feb 5, 2026grant190d agoUNIVERSITY OF WISCONSIN-MADISON — A chromatin loop controls the expression of anterograde transport genes durin...

AI grant. $524,626. PI: DONNA M NEUMANN

full page →nih reporter ↗
›Feb 5, 2026grant190d agoINDIANA UNIVERSITY INDIANAPOLIS — Critical Crystal-Bacteria and Host Interactions Contributing to Kidney Stone ...

DK grant. $728,742. PI: Qunfeng Dong

full page →nih reporter ↗
›Feb 5, 2026grant190d agoUNIVERSITY OF WASHINGTON — Early Ultrafiltration for Patients Initiating HemodialysisUniversity of Washington

DK grant. $773,901. PI: BRYAN R KESTENBAUM

full page →nih reporter ↗
›Feb 5, 2026grant190d agoVANDERBILT UNIVERSITY — Understanding dynamics and phenotypic consequences of clonal hematopoiesis ca...

AG grant. $35,593. PI: Yash Pershad

full page →nih reporter ↗
›Feb 5, 2026grant190d agoUNIVERSITY OF IOWA — Predicting Cognitive Outcomes from Stroke Using Lesion LocationUniversity of Iowa

NS grant. $582,252. PI: Aaron D Boes

full page →nih reporter ↗
›Feb 5, 2026grant190d agoBRIGHAM AND WOMEN'S HOSPITAL — Th2 Memory in Chronic Type 2 InflammationBrigham and Women's Hospital

AI grant. $3,080,416. PI: Patrick Joseph Brennan

full page →nih reporter ↗
›Feb 5, 2026grant190d agoNATIONAL JEWISH HEALTH — Uncovering the role of resident memory T cell in chronic lung disease viral i...

AI grant. $470,219. PI: Fabienne Gally

full page →nih reporter ↗
›Feb 5, 2026grant190d agoVERSITI BLOOD HEALTH, INC. — Role of Force-directed Lipid Metabolism in the Endothelial-to-Hematopoietic T...

DK grant. $127,500. PI: Wade William Sugden

full page →nih reporter ↗
›Feb 5, 2026grant190d agoUNIVERSITY OF ILLINOIS AT CHICAGO — Extracellular Vesicle Inspired Nano Vesicles for CRISPR-based Targeting of MRSA

AI grant. $440,908. PI: Francis Alonzo

full page →nih reporter ↗
›Feb 5, 2026grant190d agoVIRGINIA POLYTECHNIC INST AND ST UNIV — Transmission Dynamics and Pathogenesis of Contemporary Mayaro Virus Strains.

AI grant. $191,163. PI: James D Weger

full page →nih reporter ↗
›Feb 5, 2026grant190d agoLA JOLLA INSTITUTE FOR IMMUNOLOGY — Defining function and regulation of the novel SLE-susceptibility gene ILRUN i...Dawn Sea Therapeutics

AI grant. $476,436. PI: BENJAMIN JOACHIM SCHMIEDEL

full page →nih reporter ↗
›Feb 5, 2026grant190d agoUNIVERSITY OF MISSOURI-COLUMBIA — Renal Vascular Smooth Muscle NaV Channels: Regulation and Contribution to Hyp...

DK grant. $588,892. PI: Adebowale Adebiyi

full page →nih reporter ↗
›Feb 5, 2026grant190d agoHARVARD UNIVERSITY — Examination of Snord116 in Neuronal Ribosome Biology

NS grant. $598,687. PI: Amanda Joy Whipple

full page →nih reporter ↗
›Feb 5, 2026grant190d agoUNIVERSITY OF CHICAGO — Identification of Novel Targets for Enhancing Targeted RNA Degradation in Ant...

AI grant. $451,000. PI: Jingxin Wang

full page →nih reporter ↗
← prev
page 1 of 2
next →
$RCEL8.0100-1.35%
$PEN324.29-0.11%
$ECR
$CYTK73.45-2.90%
$XRAY11.58+1.49%